Cell-free combination, hydrogel-like material or hydrogel and uses thereof
AU2017257217A1
Marker for prognosis of a clinical outcome of an autologous intervertebral disc cell transplantation, for progress assessment/progress monitoring of an autologous intervertebral disc cell transplantation, for assessing the quality of intervertebral disc cells, for assessing the quality of an implant and/or medication for novel therapies (ATMP) for the treatment of an intervertebral disc defect, and for diagnosis of an intervertebral and/or spinal column defect
EP3364948A1
Crosslinked serum albumin containing hyaluronic acid, for the treatment of facet joint diseases
DE102016216182A1
Combination, in particular for treating a cartilage defect
DE102016213684A1
Marker and method for assessing the composition or purity of a cell culture and for in vitro determination of the identity of a cartilage cell or a synovial cell
